Order Article Reprints

Santra S, Sharapov AD, Fatykhov RF, Potapova AP, Khalymbadzha IA, Valieva MI, Kopchuk DS, Zyryanov GV, Bunev AS, Melekhin VV, et al. Xanthone-1,2,4-triazine and Acridone-1,2,4-triazine Conjugates: Synthesis and Anticancer Activity. Pharmaceuticals. 2023; 16(3):403. https://doi.org/10.3390/ph16030403

Santra, Sougata, Ainur D. Sharapov, Ramil F. Fatykhov, Anastasya P. Potapova, Igor A. Khalymbadzha, Maria I. Valieva, Dmitry S. Kopchuk, Grigory V. Zyryanov, Alexander S. Bunev, Vsevolod V. Melekhin, and et al. 2023. "Xanthone-1,2,4-triazine and Acridone-1,2,4-triazine Conjugates: Synthesis and Anticancer Activity" Pharmaceuticals 16, no. 3: 403. https://doi.org/10.3390/ph16030403

Santra, S., Sharapov, A. D., Fatykhov, R. F., Potapova, A. P., Khalymbadzha, I. A., Valieva, M. I., Kopchuk, D. S., Zyryanov, G. V., Bunev, A. S., Melekhin, V. V., Gaviko, V. S., & Zonov, A. A. (2023). Xanthone-1,2,4-triazine and Acridone-1,2,4-triazine Conjugates: Synthesis and Anticancer Activity. Pharmaceuticals, 16(3), 403. https://doi.org/10.3390/ph16030403